High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer

High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer

Background Hydrolysis of extracellular ATP to adenosine (eADO) is an important immune checkpoint in cancer immunology. We here investigated the impact of the eADO pathway in high-grade serous ovarian cancer (HGSC) using multiparametric platforms.Methods We performed a transcriptomic meta-analysis of...

Full description

Bibliographic Details
Main Authors:	John Stagg, Anne-Marie Mes-Masson, Rejean Lapointe, Pamela Thebault, David Allard, Isabelle Cousineau, Yacine Bareche, Sandra Pommey, Mayra Carneiro, Laurence Buisseret, Pavel Chrobak, Laudine Communal, Simon C Robson, Diane Provencher
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-03-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis
by: Bertrand Allard, et al.
Published: (2019-08-01)

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
by: Laudine Communal, et al.
Published: (2021-05-01)

The CD73 immune checkpoint promotes tumor cell metabolic fitness
by: David Allard, et al.
Published: (2023-06-01)

CD73 Promotes Chronic Lymphocytic Leukemia
by: David Allard, et al.
Published: (2022-06-01)

CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination.
by: David Allard, et al.
Published: (2018-01-01)

Ran GTPase: A Key Player in Tumor Progression and Metastasis
by: Zied Boudhraa, et al.
Published: (2020-05-01)

Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
by: Alexandre Sauriol, et al.
Published: (2023-02-01)

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages
by: Sarah Nersesian, et al.
Published: (2024-01-01)

Characterization of three new serous epithelial ovarian cancer cell lines
by: Hébert Josée, et al.
Published: (2008-05-01)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
by: Rancourt Claudine, et al.
Published: (2008-11-01)

RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
by: Katia Y Cáceres-Gorriti, et al.
Published: (2014-01-01)

Microdissected Tissue vs Tissue Slices—A Comparative Study of Tumor Explant Models Cultured On-Chip and Off-Chip
by: Dina Dorrigiv, et al.
Published: (2021-08-01)

The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
by: Paulina M Wojnarowicz, et al.
Published: (2012-01-01)

Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
by: Ashley H Birch, et al.
Published: (2011-01-01)

Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay.
by: Ingrid Labouba, et al.
Published: (2015-01-01)

High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality
by: Charles Dariane, et al.
Published: (2022-03-01)

A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma
by: Julyanne Brassard, et al.
Published: (2023-12-01)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
by: Cécile Le Page, et al.
Published: (2010-05-01)

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
by: Supriya Behl, et al.
Published: (2020-04-01)

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
by: Kossay Zaoui, et al.
Published: (2019-06-01)

Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
by: Asselin Eric, et al.
Published: (2007-09-01)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
by: Jung Mi Byun, et al.
Published: (2023-01-01)

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
by: Anna V. Tinker, et al.
Published: (2022-06-01)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
by: Dane Cheasley, et al.
Published: (2022-06-01)

Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
by: Chen, F, et al.
Published: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
by: Paula Punzón-Jiménez, et al.
Published: (2022-11-01)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
by: Nkechiyere G. Nwani, et al.
Published: (2018-08-01)

Methylomic Signatures of High Grade Serous Ovarian Cancer
by: Horacio Cardenas, et al.
Published: (2021-11-01)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
by: M. Sharon Stack, et al.
Published: (2018-12-01)

Educational Case: High-Grade Serous Carcinoma of the Ovary
by: Sophia Bunde BS, et al.
Published: (2021-08-01)

WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors
by: Pierre-Olivier Gaudreau, et al.
Published: (2019-05-01)

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary.
by: Ursula A Matulonis, et al.
Published: (2011-01-01)

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
by: Meinusha Govindarajan, et al.
Published: (2020-10-01)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
by: Cécile Le Page, et al.
Published: (2019-07-01)

An essential role for Ran GTPase in epithelial ovarian cancer cell survival
by: Provencher Diane M, et al.
Published: (2010-10-01)

Stimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype.
by: Marie-Andrée Forget, et al.
Published: (2012-01-01)

Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
by: Paola de Andrade Mello, et al.
Published: (2017-11-01)

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
by: Eros Azzalini, et al.
Published: (2023-10-01)

Characterizing high-grade serous papillary carcinoma of tunica vaginalis
by: Liang G. Qu, et al.
Published: (2019-09-01)